Dr. Rodney Kenneth Brannan, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 650 Joel Dr, Fort Campbell, KY 42223 Phone: 270-798-8106 |
Ms. Pamela Collins, M.A., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 650 Joel Dr, Fort Campbell, KY 42223 Phone: 270-412-9110 |
Elizabeth Lee, SLP/A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 650 Joel Dr, Fort Campbell, KY 42223 Phone: 270-798-8106 |
Dr. Christopher Lawson Audiologist Medicare: Medicare Enrolled Practice Location: 5979 Desert Storm Ave, Audiology, Lapointe Health Clinic, Fort Campbell, KY 42223 Phone: 270-412-9110 |
Melissa Leccese Audiologist Medicare: Not Enrolled in Medicare Practice Location: 650 Joel Dr, Fort Campbell, KY 42223 Phone: 270-798-8372 Fax: 270-956-0180 |
Dr. Sharleen Marie Rupp, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5979 Desert Storm Ave, Fort Campbell, KY 42223 Phone: 270-412-9110 Fax: 270-412-9131 |
Mrs. Amy A Blank, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 650 Joel Dr, Fort Campbell, KY 42223 Phone: 270-412-7804 |
Kara Bean, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 650 Joel Dr, Blanchfield Army Community Hospital, Fort Campbell, KY 42223 Phone: 270-798-8131 |
Dr. William Joseph Gottlick, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 650 Joel Dr, Fort Campbell, KY 42223 Phone: 270-412-9110 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of products in the areas of topical pain and immunology, and NovaMedica LLC, a Russian pharmaceutical company, today announced that they have signed a supply and distribution agreement providing NovaMedica the exclusive rights to market and sell Nuvo's Pennsaid 1.5% and Pennsaid 2% products in Russia and some of the Community of Independent States.
Doctors and nurses in Victoria will be given Apple iPads as part of a trial to improve internet access in Victorian hospitals. According to Health Minister Daniel Andrews' announcement yesterday, 500 iPads would be sent to graduate doctors and nurses in January and if the $500,000 pilot program goes well, the devices could be used more widely.
In the future, women with metastatic ovarian cancer could be treated with a radioactive substance that can seek and destroy tumour cells. An initial study in patients conducted jointly by the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital has found that the treatment has no unwanted side-effects.
Oxygen Biotherapeutics, Inc. announced today that the company's common stock will begin trading on the Swiss SIX Exchange with the opening of trading tomorrow, Tuesday, June 29, 2010. The company's shares will trade under the same ticker symbol, OXBT, as they currently do on the NASDAQ Capital Market.
At the 30th Reunion Interdisciplinaire de Chimothérapie Anti-Infectieuse (RICAI), Bruker announces that the Assistance Publique Hôpitaux de Paris (APHP) has selected Bruker´s IVD MALDI Biotyper as their exclusive MALDI-TOF mass spectrometry-based microbial identification tool.
› Verified 4 days ago